Robert J. Perez
Independent DirectorMr. Robert J. Perez, also known as Rob, M.B.A. serves as Senior Advisor at General Atlantic Service Company LP. He joined General Atlantic in 2019, where he served as Operating Partner of Resource Group since January 7, 2019, and Operating Partner of Operations Group, prior to serving as Senior Advisor. Mr. Perez serves as an Independent Director at Rapport therapeutics Inc. since November 2024. He has been a Director at PathAI Inc. since October 2019. He serves as Director of ImmusanT Inc. since April 2018. Mr. Perez focuses on the biopharma and life sciences sectors. He was an Independent Non-Executive Director at Immunocore Holdings plc from September 2019 until September 16, 2025. He was an Independent Director of Third Harmonic Bio Inc. from December 2021 to June 2024. He was an Independent Director of Vir Biotechnology Inc. from January 2017 until May 29, 2024. Mr. Perez served in various sales and marketing positions, including Regional Business Manager, at Zeneca Pharmaceuticals from 1987 to 1995. He served as a Regional Director, Director of Sales and Avonex Commercial Executive for Biogen from 1995 to 2001, and a Vice President of Biogen's Central Nervous System Business Unit from 2001 to 2003. He joined Cubist Pharmaceuticals Inc. in 2003, where he served as its Senior Vice President of Sales and Marketing from August 2003 to July 2004, Senior Vice President of Commercial Operations since July 2004, an Executive Vice President from August 28, 2007 to July 2, 2012, its Chief Operating Officer from August 28, 2007 to December 31, 2014, President from July 2, 2012 to December 2014, a Director from April 1, 2014 to January 2015, and Chief Executive Officer from January 1, 2015 until its sale to Merck in 2015. He served as Senior Vice President of Commercial Operations at TerraGen Discovery Inc. since July 2004. He was a Director of EPIX Pharmaceuticals Inc. from August 16, 2006 to February 28, 2009. He served as a Director of AMAG Pharmaceuticals Inc. from January 2009 to June 2, 2020. He served as a Director of Optimer Pharmaceuticals Inc. since October 24, 2013. He was previously Managing Director of Vineyard Sound Advisors LLC from March 2015 to December 2018. He served as a Director of Cidara Therapeutics Inc. from March 2015 to June 13, 2018. He served as a Director of Zafgen Inc. from September 2015 to June 2020. He served as a Director of Flex Pharma Inc. from September 2, 2015 to January 31, 2018. He served as Member of Strategic Advisory Board at GNS Healthcare Inc. since September 28, 2015. He had been Senior Advisor at PureTech Health plc since January 27, 2016. He had been Executive Chairman of Akili Interactive Labs Inc. since June 28, 2017. He served as a Director of Spark Therapeutics Inc. from January 2018 to December 17, 2019. He has been a Director of Unum Therapeutics Inc. from February 2018 to June 2019. He also served as commercial advisor of Akili Interactive Labs Inc., Board Observer at CinCor Pharma, and Board member at PANTHERx. Mr. Perez has an extensive career in the biopharmaceutical and life sciences sectors, marked by significant leadership and advisory positions across various companies. He received a Bachelor of Science in Business from California State University, Los Angeles and a Master of Business Administration from the Anderson Graduate School of Management at the University of California, Los Angeles.
Positions
- Company NameRapport Therapeutics, Inc.Stock CodeRAPPPositionIndependent DirectorColleagues
- SMSteven M. PaulFounder & Independent Chairman
- ANAbraham N. CeesayCEO, President, Treasurer & Director
- TATroy A. IgnelziChief Financial Officer
- JSJeffrey SevignyChief Medical Officer
- DBDavid BredtFounder & Chief Scientific Officer
- JIJames Irvin HealyIndependent Director
- DJDavid J. JuliusChair of Scientific Advisory Board
